首页> 外国专利> METHOD FOR DETECTING MORBIDITY RISK OF SEQUENTIAL AA- AMYLOIDOSIS IN RHEUMATOID ARTHRITIS PATIENT AND NEW OLIGONUCLEOTIDE CONTAINING MONOBASIC PLEOMORPHISM IN SAA1 GENETIC LOCUS

METHOD FOR DETECTING MORBIDITY RISK OF SEQUENTIAL AA- AMYLOIDOSIS IN RHEUMATOID ARTHRITIS PATIENT AND NEW OLIGONUCLEOTIDE CONTAINING MONOBASIC PLEOMORPHISM IN SAA1 GENETIC LOCUS

机译:检测SAA1基因位点类风湿关节炎患者和含有单核细胞多态性的新寡核苷酸的继发性AA淀粉样变性的发病风险的方法

摘要

PROBLEM TO BE SOLVED: To provide a method capable of detecting morbidity risk of sequential AA-amyloidosis of rheumatoid arthritis and to obtain a new oligonucleotide usable as a probe in the method.;SOLUTION: In this method for the detecting, the morbidity risk of sequential AA-amyloidosis of rheumatoid arthritis is detected by determining whether a base at the-13 of human serum amyloid is thymine or cytosine. The DNA contains a base sequence GCCACCGTTC CCTGG or a base sequence GCCACCGCTC CCTGG.;COPYRIGHT: (C)2002,JPO
机译:解决的问题:提供一种能够检测类风湿性关节炎继发性AA-淀粉样变性病的发病风险并获得可用作该方法的探针的新寡核苷酸的方法;解决方案:在该检测方法中,该疾病的发病风险通过确定人血清淀粉样蛋白在-13位的碱基是胸腺嘧啶还是胞嘧啶来检测类风湿性关节炎的连续AA淀粉样变性。该DNA包含一个碱基序列GCCACCGTTC CCTGG或一个碱基序列GCCACCGCTC CCTGG .;版权所有:(C)2002,JPO

著录项

  • 公开/公告号JP2002085075A

    专利类型

  • 公开/公告日2002-03-26

    原文格式PDF

  • 申请/专利权人 KAMATANI NAOYUKI;

    申请/专利号JP20000276591

  • 发明设计人 MORIGUCHI MASATO;KAMATANI NAOYUKI;

    申请日2000-09-12

  • 分类号C12N15/09;C12Q1/68;

  • 国家 JP

  • 入库时间 2022-08-22 00:56:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号